Cyclotron and linear accelerator generated scanning proton beams for lung cancer SBRT: Interplay effects and mitigations.

Autor: Liu CW; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Kolano AM; Applications of Detectors and Accelerators to Medicine (ADAM) SA, Meyrin, Switzerland.; Advanced Oncotherapy (AVO) plc, London, UK., Gray T; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Stephans KL; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Videtic GMM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA., Farr JB; Applications of Detectors and Accelerators to Medicine (ADAM) SA, Meyrin, Switzerland.; Advanced Oncotherapy (AVO) plc, London, UK., Xia P; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Publikováno v: Medical physics [Med Phys] 2024 Jun; Vol. 51 (6), pp. 3985-3994. Date of Electronic Publication: 2024 Apr 29.

ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.

Autor: Simone CB 2nd; Department of Radiation Oncology, New York Proton Center, New York, New York., Bradley J; Department of Radiation Oncology, Emory University School of Medicine, Atlanta, Georgia., Chen AB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas., Daly ME; Department of Radiation Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California., Louie AV; Department of Radiation Oncology, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada., Robinson CG; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Videtic GMM; Department of Radiation Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio., Rodrigues G; Department of Radiation Oncology, London Health Sciences Cancer, London, Ontario, Canada. Electronic address: George.Rodrigues@lhsc.on.ca.

Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2023 May-Jun; Vol. 13 (3), pp. 195-202.

Association of Radiotherapy Duration With Clinical Outcomes in Patients With Esophageal Cancer Treated in NRG Oncology Trials: A Secondary Analysis of NRG Oncology Randomized Clinical Trials.

Autor: Hallemeier CL; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Moughan J; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Haddock MG; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota., Herskovic AM; Department of Radiation Oncology, Rush University Medical Center, Chicago, Illinois., Minsky BD; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston., Suntharalingam M; Department of Radiation Oncology, University of Maryland and Greenebaum Comprehensive Cancer Center, Baltimore., Zeitzer KL; Department of Radiation Oncology, Albert Einstein Medical Center, Philadelphia, Pennsylvania., Garg MK; Department of Radiation Oncology, Montefiore Medical Center-Moses Campus, Bronx, New York., Greenwald BD; Department of Gastroenterology and Hepatology, University of Maryland and Greenebaum Cancer Center, Baltimore., Komaki RU; Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston., Puckett LL; Department of Radiation Oncology, Medical College of Wisconsin and Zablocki Veterans' Administration Medical Center, Milwaukee., Kim H; Department of Radiation Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri., Lloyd S; Department of Radiation Oncology, University of Utah Health Science Center, Salt Lake City., Bush DA; Department of Radiation Oncology, Loma Linda University Cancer Institute, Loma Linda, California., Kim HE; Department of Radiation Oncology, Wayne State University/Karmanos Cancer Institute, Detroit, Michigan., Lad TE; Department of Medical Oncology, John H. Stroger Jr Hospital of Cook County, Chicago, Illinois., Meyer JE; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Okawara GS; Department of Radiation Oncology, McMaster University, Juravinski Cancer Centre, Hamilton, Ontario, Canada., Raben A; Department of Radiation Oncology, Christiana Care Health Services Inc Community Clinical Oncology Program, Newark, Delaware., Schefter TE; Department of Radiation Oncology, University of Colorado, Aurora., Barker JL Jr; Department of Radiation Oncology, US Oncology Texas Oncology-Sugar Land, Fort Worth., Falkson CI; Department of Medicine, Hematology/Oncology, University of Rochester, Rochester, New York., Videtic GMM; Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, Ohio., Jacob R; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham., Winter KA; NRG Oncology Statistics and Data Management Center/American College of Radiology, Philadelphia, Pennsylvania., Crane CH; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.

Publikováno v: JAMA network open [JAMA Netw Open] 2023 Apr 03; Vol. 6 (4), pp. e238504. Date of Electronic Publication: 2023 Apr 03.

Is adaptive planning necessary for patients with large tumor position displacements observed on daily image guidance during lung SBRT?

Autor: Ma T; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA; Department of Radiation Oncology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298., Liu CW; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA., Ahmed S; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA., Yu N; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA., Qi P; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA., Stephans KL; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA., Videtic GMM; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA., Xia P; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH 44195, USA. Electronic address: xiap@ccf.org.

Publikováno v: Medical dosimetry : official journal of the American Association of Medical Dosimetrists [Med Dosim] 2022 Autumn; Vol. 47 (3), pp. 207-215. Date of Electronic Publication: 2022 Apr 02.

A Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC.

Autor: Lemmon CA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Videtic GMM; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Murthy S; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio., Stephans KL; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Shapiro M; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Ahmad U; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio., Raymond D; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio., Velcheti V; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.; Present Address: Division of Hematology and Medical Oncology, Perlmutter Cancer Center, New York University Langone School of Medicine, New York, New York., Bribriesco A; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Heart and Vascular Institute, Cleveland, Ohio., Jia X; Department of Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, Ohio., Stevenson J; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Pennell NA; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.

Publikováno v: JTO clinical and research reports [JTO Clin Res Rep] 2022 Jun 15; Vol. 3 (7), pp. 100359. Date of Electronic Publication: 2022 Jun 15 (Print Publication: 2022).